| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |